PRRT2 and neoplasm: However, dendritic cells loaded with lysates of PKC-(shRNA-AIRE) cells significantly improved survival times of PKC tumour-bearing mice, an effect which was significantly further improved in combination with anti-PD-1 ICB (Fig. 5A).